DIETHYLPROPION HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Diethylpropion Hydrochloride patents expire, and when can generic versions of Diethylpropion Hydrochloride launch?
Diethylpropion Hydrochloride is a drug marketed by Lannett Co Inc, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, and Watson Labs. and is included in ten NDAs.
The generic ingredient in DIETHYLPROPION HYDROCHLORIDE is diethylpropion hydrochloride. Thirteen suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diethylpropion Hydrochloride
A generic version of DIETHYLPROPION HYDROCHLORIDE was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DIETHYLPROPION HYDROCHLORIDE?
- What are the global sales for DIETHYLPROPION HYDROCHLORIDE?
- What is Average Wholesale Price for DIETHYLPROPION HYDROCHLORIDE?
Summary for DIETHYLPROPION HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 10 |
